Stocks to Watch on Thursday, January 8, 2026: Markets closed Wednesday on a muted note, extending the ongoing corrective phase. The Nifty has edged closer to its first support level at the 20-day DEMA
after the recent decline. Analysts believe the index is likely to find near-term support in the 26,000–26,100 range, while a stronger base is seen around the 25,800 mark.
Results today: Elecon Engineering Company, Transformers and Rectifiers (India), Eimco Elecon (India), Toyam Sports and Yuranus Infrastructure are scheduled to announce their quarterly results today.
Tata Steel: In its Q3 update, Tata Steel India reported its “best-ever quarterly” crude steel production at 6.34 million tonnes. Output rose 12 per cent quarter-on-quarter and year-on-year, aided by higher production at the Jamshedpur and Kalinganagar facilities. Tata Steel Netherlands recorded liquid steel production of 1.68 million tonnes in Q3 FY26, while deliveries stood at 1.40 million tonnes.
NCL Industries: The company said cement production in Q3 FY26 increased 5 per cent year-on-year to 6,94,854 metric tonnes. Cement dispatches rose to 6,93,229 metric tonnes, compared with 6,62,936 metric tonnes in the year-ago period.
Meesho: Megha Agarwal, general manager for business at Meesho, has resigned, marking the first senior leadership exit since the e-commerce firm’s public listing in December.
Shriram Finance: Voting advisory firms have backed the company’s resolutions related to Japan’s MUFG Bank investing $4.4 billion for a 20 per cent stake. This is set to be the largest foreign direct investment in India’s financial services sector and will give MUFG a stake in the country’s second-largest retail NBFC.
Infosys: The IT major has partnered with Cognition to deploy Devin, an advanced autonomous AI software engineer, across internal teams and global client projects. By integrating Devin with Infosys Topaz Fabric, the company aims to accelerate product launches, improve developer productivity and speed up legacy system modernisation.
IndiGo: The Competition Commission has sought information from IndiGo and aviation regulator DGCA to examine whether the airline engaged in unfair business practices following widespread flight cancellations last month, PTI reported.
Eternal: The parent of Zomato and Blinkit has received a GST demand order, along with interest and penalty, amounting to Rs 3.69 crore for the period April 2019 to March 2020. The order was issued by the Additional Commissioner of State Tax (Appeals), West Bengal.
IIFL Capital Services: US-based alternative asset manager TPG has revived talks to invest in IIFL Capital Services, the broking and wealth arm of the IIFL Group, according to reports. TPG is exploring the purchase of around a 20 per cent stake and is conducting due diligence on the proposed transaction.
Inox Green Energy Services: The company and its subsidiary, Inox Solar, have raised Rs 3,100 crore in equity funding from global and domestic investors, including CalPERS, SUN Group Global and Authum Investments.
MCX: Multi Commodity Exchange Clearing Corporation, a subsidiary of MCX, has received SEBI approval for the appointment of Rishi Nathany as managing director and CEO.
Samvardhana Motherson International: The company has progressed with its joint venture with South Korea’s Egtronics Co. Ltd and has incorporated a wholly owned subsidiary, Motherson Egtronics Electronics Solutions Limited, to execute the partnership’s objectives.
Gland Pharma: The company has received USFDA approval for its abbreviated new drug application for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 per cent (OTC).
Medicamen Biotech: The firm has secured European Union approval for the registration of Paracetamol from the Danish Medicines Authority, in collaboration with XGX Pharma, Denmark.
Cipla: The drugmaker clarified that its supply partner, Pharmathen International S.A., received nine inspectional observations from the USFDA following an audit of its Rodopi, Greece manufacturing facility conducted between November 10 and November 21, 2025. The Form 483 details became public on January 7, 2026. Pharmathen manufactures Lanreotide Injection for Cipla’s US subsidiary, and the clarification was issued after stock exchanges sought details on media reports related to the regulatory action.
Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.
